Abstract
Solid pseudopapillary tumor of the pancreas (SPTP), also known as solid and papillary epithelial neoplasm of the pancreas, is a rare pancreatic exocrine tumor that is difficult to diagnose before surgery. Pancreatic panniculitis is a rare type that occurs in less than 3% of all patients with pancreatic diseases. We here report a 19-year-old woman who presented with persistent left upper quadrant pain without obvious cause for 1 d. The patient also developed subcutaneous nodules involving lower abdomen bilaterally and lower limbs, and subcutaneous nodules were pathologically diagnosed as pancreatic panniculitis. Plain abdominal computed tomography revealed a soft-tissue mass in the body and tail of the pancreas, which was closely associated with the gastric wall. Contrast-enhanced ultrasound showed inhomogeneous echogenicity in the anterior pancreatic body, which had blurred parenchymal demarcation of the body and tail of the pancreas. Contrast-enhanced abdominal computed tomography revealed a mixed density mass with solid and cystic components in the body and tail of the pancreas, and the solid component was markedly enhanced. The lesion was pathologically diagnosed as SPTP after laparoscopic resection. Clinicians should be aware of the clinical manifestation, diagnosis, and treatment of pancreatic panniculitis and SPTP.
INTRODUCTION
Pancreatic panniculitis is a rare complication of panc reas disorders occurring in 1%3% of patients, most often accompanied by the pancreatic carcinoma. It often presents multiple and redbrown subcutaneous nodules. The pathogenesis is not fully understood, but it is thought to result from lipolysis and fat necrosis with secondary tissue inflammation induced by pan creatic enzymes [1] . Solid pseudopapillary tumor of the pancreas (SPTP) often occurs in young women, with an average age of 25 years. While the histogenetic origin of SPTP is still unclear, it may arise from the cells related with the gonadal ridge/ovarian primordium during embryogenesis or the embryonic neural crest cells. SPTP exhibits two histological features: Solid and pseudopapillary. In fact, the papillary structure is composed of pseudopapillae that are formed due to degeneration of tumor cells, decreased adhesion of cells, and cystic cavity formation. Clinically, it is usually manifested as an epigastric mass or epigastric pain, and some patients present with both epigastric mass and pain. Some patients may only have epigastric discom fort or fatigue, while others do not have any symptoms. In those asymptomatic patients, pancreatic masses are accidentally found only during routine examina tions, and the results of routine biochemical tests are normal [2] . SPTP is unresponsive to radiotherapy or chemotherapy, and surgical resection is the primary treatment of choice. In this report, we describe the diagnosis and treatment of SPTP accompanied with pancreatic panniculitis in a young woman. 
DISCUSSION
Pancreatic panniculitis is a rare cause of subcutane ous fat necrosis secondary to elevated serum levels of pancreatic enzymes. It is most often associated with pancreatic cell carcinoma, but has also been seen in patients with pancreatitis. Systematic evidence on pan creatic panniculitis is limited [3] . SPTP is a rare tumor, accounting for about 3% of all pancreatic tumors. It is December 6, 2018|Volume 6|Issue 15| The clinical manifestations of SPTP are atypical. In most cases, a mass is often found within the abdomen accidentally or during physical examination, with or without gastrointestinal symptoms, such as the upper abdominal discomfort and dyspepsia [46] . These non specific gastrointestinal symptoms are mostly associa ted with compression of nearby organs by tumors. In some special cases, SPTP can cause acute pancreatitis or spontaneous rupture of the pancreatic pseudocyst, which is clinically manifested as acute abdominal pain. Routine blood test, liver function test, renal function test, and tests for the endocrine/exocrine functions of pancreas often show normal results, and the levels of various tumor markers are usually within the normal ranges.
Imaging examination is crucial for the preoperative diagnosis of SPTP. It can determine the size and loca tion of the tumor and its relationship with surrounding tissues, thus providing detailed information to make a surgical protocol [2, 7, 8] . The typical ultrasonographic finding of SPTP is a cystic/solid mass with mixed density in the pancreas. When the tumor is small, homogen eous hypoechoic echoes can be detected. Color doppler flow imaging often reveals a few blood flow signals on the capsule or parenchyma of the tumor. CT is the most commonly used imaging method for SPTP. On CT scans, SPTP is often round and oval, with lobulation. It has a welldefined border with the pancreas, and its margin is smooth. The solid part is often located in the periphery of the tumor, and the cystic part inside the tumor. The tumor can be located at any part of the pancreas. After enhancement, the parenchyma part is slightly enhanced during arterial phase and markedly enhanced during portal venous phase. The cystic part is hypodense before and after enhancement [911] . In our case, routine blood test, serum amylase and lipase test, and liver function test showed slight or obvious abnormalities before the operation, which were significantly improved after treatment. Subcutaneous nodules involving lower abdomen bilaterally and lower limbs reduced after treatment. The diagnosis of SPTP and the differential diagnosis of this lesion from other pancreatic diseases were mainly based on abdomi nal contrastenhanced CT and abdominal contrast enhanced ultrasound. A cystic/solid mass with mixed density was found in the body and tail of the pancreas, 
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Zhang MY et al . Solid pseudopapillary tumor of the pancreas with a welldefined border. Nodular calcifications were seen inside the lesion, and the lesion was fed by the common hepatic artery and a branch of splenic artery. The spleen was slightly enlarged, along with regional portal hypertension. Surgery was performed after adequate preparation, during which a mass with areas of necrosis was found in the body and tail of the pancreas. The tumor had a poorlydefined border with pancreatic body and tail. It was tightly adhered to the splenic vein, and several of its nourished vessels joined the splenic vein. Postoperative pathology confirmed the result of preoperative imaging diagnosis. Immunophenoty ping showed synaptophysin (+), CD56(+), CD10(+), βcatenin(+), vimentin (+), and AE1/AE3(+), which met the diagnostic criteria for SPTP, and was consis tent with the histopathological diversity of SPTP [1214] . Vimentin, βcatenin, synaptophysin, neuronspecific enolase, α1antitrypsin (α1AT), S100, neural cell ad hesion molecule CD56, and cluster of differentiation 10 (CD10) can all be expressed in SPTP [1517] . At present, surgical resection is the only radical treatment for SPTP. However, laparoscopic surgery is a challenging technique, and the selection of specific surgical approaches depends on the location and size of tumor and the findings of intraoperative pathological examination [18] . The most common postoperative complication is pancreatic fistula, followed by pancreatitis, gastrointestinal bleeding, and pseudocyst. The prognosis of SPTP is good, and the postoperative survival rate is high. If the tumor is located in the body and tail of the pancreas, resection of the body and tail of the pancreas is feasible. If the tumor invades or is closely related to the splenic ves sels, pancreatectomy combined with resection of the body and tail of the pancreas can be performed [1922] . No evidence is yet available that local resection has a higher risk of recurrence or metastasis than radical resection. Therefore, clinicians should be aware of the clinical manifestation and treatment of pancreatic pan niculitis [23, 24] . Although SPTP has good prognosis and the postoperative 5year survival rate is high, efforts should be made to increase further diagnostic accuracy and optimize therapeutic methods, so as to improve the quality of life of SPTP patients.
ARTICLE HIGHLIGHTS

Case characteristics
A 19-year-old woman presented with persistent left upper abdominal pain without obvious cause for 1 d. The patient also developed subcutaneous nodules involving lower abdomen bilaterally and lower limbs. An irregular mass was found in the pancreatic body and tail on plain abdominal computed tomography (CT), contrast-enhanced abdominal CT, and contrast-enhanced ultrasound.
Clinical diagnosis
Solid pseudopapillary tumor of the pancreas (SPTP), pancreatic panniculitis.
Differential diagnosis
Pancreatic cancer.
Laboratory diagnosis
Abnormal laboratory findings included the results of routine blood: Neutrophilto-lymphocyte ratio 85.5% (normal range: 40%-75%), hemoglobin 88 g/L (normal range: 115-150 g/L). Liver function test showed albumin 30 g/L (normal range: 40-55 g/L) and alanine aminotransferase 62 U/L (normal range: 8-40 U/L). The result of serum amylase was 869 U/L (normal range: 40-100 U/L), and serum lipase was 759 U/L (normal range: 0-110 U/L).
Imaging diagnosis
Contrast-enhanced abdominal CT revealed a cystic/solid mass with mixed density in the body and tail of the pancreas.
Pathological diagnosis
SPTP, pancreatic panniculitis.
Treatment
Laparoscopic resection of the mass in the pancreatic body and tail with preservation of the spleen.
Related reports
Some articles have described the imaging diagnosis and treatment of SPTP and pancreatic panniculitis, as shown in the References.
Experiences and lessons
Clinicians should be aware of the clinical manifestation and treatment of pancreatic panniculitis. Although SPTP has good prognosis and the postoperative 5-year survival rate is high, efforts should be made to increase further diagnostic accuracy and optimize therapeutic methods, so as to improve the quality of life of SPTP patients.
